Ratnakar Securities

Mobile Trading
COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

PFIZER LTD.

NSE : PFIZERBSE : 500680ISIN CODE : INE182A01018Industry : Pharmaceuticals & DrugsHouse : Pfizer - MNC
BSE4995.25-7.55 (-0.15 %)
PREV CLOSE ( ) 5002.80
OPEN PRICE ( ) 4992.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 581
TODAY'S LOW / HIGH ( )4988.70 5006.90
52 WK LOW / HIGH ( )3742.9 5987.65
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 21-11 1950
Management Info
Pradip Shah - Chairman Meenakshi Nevatia - Managing Director
Registered Office

Address The Capital, 1802/1901,Plot No. C-70, G Block,Bandra Kurla Complex, Bandra (East),
Mumbai,
Maharashtra-400051

Phone 022 6693 2000

Email contactus.india@pfizer.com

Website www.pfizerltd.co.in

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
 Listing : BSE, NSE
NEWS
18Nov Pfizer inches up on launching new medi
Pfizer is currently trading at Rs. 5064.00, up by 5.75 points or 0.11% f..
17Nov Pfizer launches new medication for mig
Pfizer has launched a new medication for migraine treatment. The company..
05Sep Pfizer signs MoU with DPIIT
Pfizer and Department for Promotion of Industry and Internal Trade (DPII..
12Aug Pfizer launches 20-valent Pneumococcal
Pfizer has launched its next-generation 20-valent pneumococcal conjugate..
12Aug Pfizer surges on launching 20-valent P
Pfizer is currently trading at Rs. 5134.85, up by 94.05 points or 1.87%..
MORE
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit1890.27676
Gross Profit 2553.7 10160.9
Operating Profit 2717.89124.8
Net Sales 6423.422813.5
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Alkem Laboratories (BSE)
up  5689.30 (1.38%)
M.Cap ( in Cr)68024.12
Abbott India (BSE)
up  28869.35 (0.15%)
M.Cap ( in Cr)61345.35
Glaxosmithkline Phar (BSE)
up  2543.10 (1.35%)
M.Cap ( in Cr)43081.65
Wockhardt (BSE)
up  1360.10 (2.16%)
M.Cap ( in Cr)22100.56
RPG Life Sciences (BSE)
up  2228.80 (1.27%)
M.Cap ( in Cr)3686.22
MORE
Shareholding Pattern
PROMOTERS 63.92%
FI/BANKS/INSURANCE 5.37%
NON-INSTITUTION 16.37%
MUTUAL FUNDS/UTI 11.74%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
FAQs
079-49005200 / 01 / 02
info@ratnakarsecurities.com
Download Mobile App

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
products
about us
usefull links
news room

Ratnakar Securities Pvt. Ltd. : SEBI Registration No. of NSE, BSE : INZ000191735 | SEBI Registration No. of NSDL : IN-DP-NSDL-66-88
Ratnakar Commodities Pvt. Ltd : SEBI Registration No. of MCX : INZ000024138
Investor Grievance ID : investorgrievance@ratnakarsecurities.com
Online Dispute Resolution Portal - SMART ODR
To File A Complaint on SCORES Click Here
For Nomination, Please Click Here
To Close Account, Please Click Here
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.